Valneva SE
VALN----
Valneva SE (VALN)
Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IX...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Valneva SE Analyst Rating
View MoreForecast & Rating
May 15, 2026Price forecast
$12.20155.23%
Forecast & RatingBuy
4analysts
- Strong buy75.00%
- Buy0.00%
- Hold0.00%
- Sell25.00%
- Strong sell0.00%
News
- PUBT · 2 days ago, 10:46 AM
Valneva to report first-half results, host webcast update
- PUBT · Jul 21 at 06:12 AM
Goldman Sachs cuts Valneva stake below 5% to 4.14%
- PUBT · Jul 20 at 08:38 AM
D.E. Shaw discloses net short position in Valneva shares
- PUBT · Jul 17 at 08:37 AM
D.E. Shaw discloses net short position in Valneva
- PUBT · Jul 10 at 08:44 AM
PDT Partners discloses net short position in Valneva shares
- PUBT · Jul 2 at 11:01 AM
Valneva reports 189,771,237 shares outstanding, 204,363,605 total voting rights as of June 30, 2026
